| Product Code: ETC10709054 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Opioid Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Opioid Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Opioid Market - Industry Life Cycle |
3.4 Australia Opioid Market - Porter's Five Forces |
3.5 Australia Opioid Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Australia Opioid Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Opioid Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Australia Opioid Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Opioid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Australia |
4.2.2 Growing awareness and acceptance of opioid use for pain management |
4.2.3 Rising healthcare expenditure and investment in pain management therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment and increasing scrutiny on opioid prescribing practices |
4.3.2 Concerns over opioid addiction, misuse, and abuse |
4.3.3 Shift towards alternative pain management therapies and treatments |
5 Australia Opioid Market Trends |
6 Australia Opioid Market, By Types |
6.1 Australia Opioid Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Opioid Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Australia Opioid Market Revenues & Volume, By Natural Opioids, 2021 - 2031F |
6.1.4 Australia Opioid Market Revenues & Volume, By Semi-Synthetic Opioids, 2021 - 2031F |
6.1.5 Australia Opioid Market Revenues & Volume, By Synthetic Opioids, 2021 - 2031F |
6.1.6 Australia Opioid Market Revenues & Volume, By Combination Formulations, 2021 - 2031F |
6.2 Australia Opioid Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Opioid Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.3 Australia Opioid Market Revenues & Volume, By Anesthesia, 2021 - 2031F |
6.2.4 Australia Opioid Market Revenues & Volume, By Cough Suppression, 2021 - 2031F |
6.2.5 Australia Opioid Market Revenues & Volume, By Opioid Dependence Treatment, 2021 - 2031F |
6.3 Australia Opioid Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Australia Opioid Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Australia Opioid Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Australia Opioid Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.3.5 Australia Opioid Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Australia Opioid Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia Opioid Market Revenues & Volume, By Chronic Pain Patients, 2021 - 2031F |
6.4.3 Australia Opioid Market Revenues & Volume, By Surgical Patients, 2021 - 2031F |
6.4.4 Australia Opioid Market Revenues & Volume, By Cancer Patients, 2021 - 2031F |
6.4.5 Australia Opioid Market Revenues & Volume, By Rehabilitation Centers, 2021 - 2031F |
7 Australia Opioid Market Import-Export Trade Statistics |
7.1 Australia Opioid Market Export to Major Countries |
7.2 Australia Opioid Market Imports from Major Countries |
8 Australia Opioid Market Key Performance Indicators |
8.1 Number of prescriptions for opioid medications |
8.2 Patient satisfaction and pain management outcomes with opioid use |
8.3 Adoption rate of opioid risk mitigation strategies |
8.4 Opioid-related healthcare costs and expenditures |
8.5 Overall opioid utilization patterns and trends |
9 Australia Opioid Market - Opportunity Assessment |
9.1 Australia Opioid Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Australia Opioid Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Opioid Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Australia Opioid Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Opioid Market - Competitive Landscape |
10.1 Australia Opioid Market Revenue Share, By Companies, 2024 |
10.2 Australia Opioid Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here